INTRODUCTION
Alopecia areata (AA) is a disease that causes marked cosmetic deformity and psychological morbidity, leading to hair loss on the scalp, face and body. Although, the pathogenesis of AA is poorly understood, evidence which suggests that T cells and cytokines play an important role is accumulating [1] .
Interleukin-23 (IL-23) is a heterodimeric cytokine produced predominantly by activated antigen presenting cells, such as macrophages and dendritic cells. The cytokine is composed of a unique p19 subunit and a p40 subunit that is shared with the Th1 signature cytokine, IL-12 [1] .
Cytokines produced by Th17 cells are highly pro-inflammatory and are now associated with various autoimmune diseases, such as psoriasis, rheumatoid arthritis and AA [2] . The IL-23/IL-17 axis, therefore, is one of the main cytokine axes driving the pathogenesis of various autoimmune diseases. Sera IL-23 and the number of Th17 cells were elevated in various autoimmune diseases patients compared to control subjects [3] .
PATIENTS AND METHODS
This study was carried out in the dermatology department of Fayoum University Hospital. Lab work was performed at the Clinical Pathology Department of Fayoum University Hospital cross sectional study.
Our study included 80 individuals divided into two groups:
Group 1:
This group included 40 patients of AA without atopic background.
Group 2:
This group included 40 apparently healthy volunteers as controls which are age and sex matched with the patient group.
Exclusion criteria:
Patients were excluded from the study if there was any of the following: 
Comparison between levels of IL-23 in patients according to disease progression

DISCUSSION
Alopecia areata is a common, chronic inflammatory disease characterized by nonscarring hair loss on the scalp or any hairbearing area of the body. Although the pathogenesis of AA has not been fully elucidated, clinical and experimental studies have shown that AA is a T cell-mediated autoimmune disease that targets the anagenstage hair follicles [4] . Furthermore, an alteration of the CD4+T cell subsets, including Th1, Th2, Th17 cells, and regulatory T cells, has been found in AA subjects [5] .
There was a statistically significant difference between the 2 groups regarding level of IL-23 as IL-23 in group 1 was 807.19±969.293 and in group 2 was 1359.8±1149. This was in agreement with [6] .
Another study found that immunohistochemistry of IL-23 showed positive cells in the intra-follicular epithelium and peribulbar dermis in affected hair follicles of pretreatment lesional scalp and very few cells in post-treatment AA scalp [7] , raising stronger suggestion for IL-23 role in the AA disease pathogenesis [8] .
CONCLUSION
Our study revealed higher serum level of IL-23 in AA patient, so it may suggests it's role in AA pathogenesis.
